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Abstract
Alzheimer’s disease is the most common type of dementia in occidental countries. The
majority of the cases develop the disease for no genetic reasons; therefore, it is crucial to
establish which environmental factors trigger the development of the disease. It has been
proposed that nutritional habits, especially main components of Western countries’ diet
such as saturated fat or cholesterol, increase the risk for development of Alzheimer’s
disease (AD) and/or accelerate the onset of the disease, which is a big concern in countries
where obesity is a public health problem. It is crucial to understand the links between
alimentary habits and the development of AD and other types of dementia. A possible
mechanism is the disruption of blood–brain barrier (BBB), which is the protection of the
brain from circulating blood. Such disruptions can result from consuming high-fat diet
(HFD) or high-cholesterol diet (HCD) and inflammation produced by alteration in brain
vasculature resulted for chronic consumption of such type of diets. What has named a
"Systemic view" comprises the idea that; what happens outside of the brain environ‐
ment does affect  brain functioning and the modifications experienced in the brain
environment resulted from the influence of external factors will affect the entire body. In
the current chapter, we will review the state of the art in the studies of the impact of a diet
rich in fat or cholesterol on the brain and how the alterations induced in other organs can
impact brain functioning increasing the susceptibility of development of dementia.
Keywords: high-fat diet, high-cholesterol diet, Alzheimer's disease, blood–brain barri‐
er, brain plasticity, cognition
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1. Introduction
In the recent decades, the population in the industrialized Western countries has become
remarkable sedentary and have had a considerable increase in the intake of what has been called
"fast food," meals that are rich in fat and carbohydrates and contain elevate levels of cholester‐
ol as well. The elevated consumption of fast food has had a strong impact on public health, which
has important repercussions in several levels including an economic impact due to the elevated
cost of a chronic use of specialized health services and a detrimental effect in both, life quality
and expectancy for the patients. Among the adverse health effects of this type of diet, we can
mention obesity, vascular diseases, and metabolic syndrome, and it has been recently pro‐
posed that it can increase the risk of developing Alzheimer’s disease (AD), which is the most
common type of dementia in elderly people. It is considered that a particular type of diet could
accelerate the progress of the disease for a not yet well-known mechanism [1]. It is a revolu‐
tionary idea, since we have had for several years the conception that brain is actually protect‐
ed  by  the  blood–brain  barrier  (BBB);  however,  experimental  evidence  suggests  that  the
consumption of diets rich in fat can disrupt the permeability of BBB, making it vulnerable to
systemic molecules that could trigger degenerative processes [1, 2].
In the current chapter, we will review the state of the art related to the impact of diets rich in
fat or cholesterol on the brain, and how the alterations induced in other organs can impact
brain functioning and could increase the susceptibility to develop dementia. The bibliographic
revision was carried out running an exhaustive search on the research articles related to the
topic employing the database of the US National Library of Medicine, National Institutes of
Health, PubMed.gov. Firstly, reviewing the most recent papers and those with the most
relevant information. Thereafter, we carefully followed the references cited by the reviewed
articles in order to study the grounding data on the subject and which direction it followed
until our days in order to document the accuracy and evolution of the data.
2. Findings on amyloid-β production induced by saturated fat diet in
noncerebral tissue
One of the histopathological hallmarks of AD is the extracellular deposition of amyloid-β
peptide (Aβ) in the brain. It is widely accepted that Aβ deposition occurs when the neuronal
synthesis of the peptide exceeds the clearance capacity [3, 4]. However, some decades ago, the
idea was proposed that Aβ generated systemically could pass the BBB and be deposited in the
brain, since Aβ was detected in noncerebral biological fluids. Such idea raised from grounding
data of Seubert et al. [5], who demonstrated that Aβ fragment comprising the amino acids 13–
28 can be detected in cerebrospinal fluid and plasma of several species including human as
well as in conditioned media from human brain cell cultures. It originated the idea that cerebral
Aβ deposits could be generated systemically and for unknown mechanism, accumulate in the
brain where they affect the capacity, to be clear, increasing the amount of the peptide and
eventually form the extracellular deposits. A good amount of data has focused on this idea
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since then. An interesting line of study has focus on the production of Aβ by noncerebral tissue
induced by consumption of diets rich in fat. One of the physiological functions of Aβ is relate
to lipids metabolism and many Aβ transport proteins have been associated with lipids in
vivo [6]. The association of the Aβ soluble fraction with high-density lipoproteins from healthy
human plasma and cerebrospinal fluid was reported as well [7, 8]. The association between
lipids and Aβ was demonstrated in a very elegant study where Aβ activity was followed
labeling it with radioactivity, and it was found that the peptide is expressed in tissues rich in
fat, such as spleen, marrow, liver, adipose tissue, brain, kidney, lung, and skeletal muscle. It
was shown that the expression of Aβ is associated with postprandial lipoproteins such as
chylomicrons, lipoproteins that are in charge to move dietary fat from intestine to the target
organs. These associations remain during lipolysis and tissue uptaking processes [9]. There‐
fore, it can be proposed that an increased plasmatic amount of such proteins containing Aβ
could produce an imbalance and could even be delivered in brain contributing to cerebral
amyloidosis, one of the responsible events related to Alzheimer’s disease [9, 10]. The natural
question is: how can we increase the amount of Aβ associated to postprandial lipids? One
answer is the intake of diets rich in fat or cholesterol because they could break the balance of
lipids content, but by which way? An interesting direction has been to study the expression of
Aβ in organs rich in lipids and if such expression is regulated by fat or cholesterol diets.
Koudinov et al. [11] reported that hepatocytes secrete amyloid-β as a lipoprotein complex.
Another organ where it has been documented that Aβ is produced is the small intestine. Given
the evidence that Aβ is associated to postprandial lipoproteins, chylomicrons, Galloway et al.
[10] followed this line of evidence and studied small intestinal epithelial cells (where the
chylomicrons are produced). They fed wild-type mice with low- or high-fat diet. After six
months of treatment they determinate by immunohistochemistry, the expression of the
amyloid precursor protein in absorptive cells in the small intestine and observed a greater
expression of this molecule in small intestinal epithelial cells of high-fat fed animals, whereas
animals fasting 65 h did not show any expression. There is another study where the group of
John CL Mamo evaluated the expression of Aβ in enterocytes after a low- or high-fat diet with
1% cholesterol in apoliprotein E (apo E) (-/-) knockout mice. Apoliprotein E is a lipoprotein
that modulates Aβ biogenesis [12–14]. After six months of dietary treatment, the small intestine
of apo E (-/-) KO mice fed with low-fat diet showed the same levels of expression of Aβ as the
wild-type animals detected by immunohistochemistry. On the other hand, both groups of
animals, wild-type and apo E (-/-) KO mice fed with high-fat diet, showed an increased
expression of Aβ in enterocytes being higher in the KO animals. Also in these study, the group
evaluates villi length between the groups treated, finding that the high-fat diet did not affect
villi length in apo E(-/-) KO mice, but interestingly there is an increase in villi length of KO
mice treated with low-fat diet when compared with wild-type mice under the same dietary
conditions [15]. These groups also carried out a very elegant study to corroborate the associ‐
ation of Aβ production with recently generated lipoproteins, employing three-dimensional
immunofluorescence microscopy and determinated that Aβ produced by enterocytes certainly
has a clear colocalization with chylomicrons in small intestine enterocyte after three months
of dietary treatment (free of cholesterol). They found that the amount of Aβ colocalizing with
chylomicrons reaches the double [16]. These data together confirms the presence of Aβ in
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lipoproteins generated in small intestine and that a diet rich in fat could increase the production
of transport lipoproteins. However, the open question stills remains: how this Aβ produced
systemically reaches the brain? (Figure 1). Further studies are necessary to establish if indeed
an imbalance in lipids production induced by diet can promote the delivery of these systemic
Aβ to brain and induce cerebral amyloidosis.
Figure 1. The ingestion of food rich on fat and cholesterol can increase the amount of postprandial lipoproteins chylo‐
microns. An increased production of chylomicrons can lead to an overproduction of Aβ and potentially produce an
unbalance on Aβ processing and lead to cerebral amyloidosis.
3. Effect on vascularity and BBB integrity
The brain is a very well-protected organ with two barrier systems. One is a highly specialized
microvascular endothelial system known as blood brain barrier (BBB), its function is to protect
the brain from the entry of damaging substances and at the same time, allows the entry of
nutrients as well as endocrine signals by means of an active transport and a passive diffusion
system. The second is the choroid plexus, whose function is to prevent the entry of blood in
the cerebrospinal circulation [17]. An unbalance in such systems could lead to disease condi‐
tions regarding the entrance of damaging molecules or disrupting the entrance of proper
nutrients or endocrine signals. A good body of data has focused in study; how dietary habits
can trigger BBB disruption? A longitudinal study, carried out in Sweden, evaluated the
integrity of BBB in vivo in 81 women with a wide range of body size, who acceded to receive
a lumbar puncture in order to obtain cerebrospinal fluid and compared the index of albumin
content. Albumin is a constitutive protein that is absent in the brain, since its access is stopped
by the BBB; therefore its presence in cerebrospinal fluid is a sign of disruption of the protection
systems. Among these large group studied, the obese and overweight women between 70 and
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84 years had the highest amount of albumin reported as the ratio of albumin in cerebrospinal
fluid/Serum albumin (CSF/S albumin). Interestingly, they found a correlation between low
levels of sex hormone binding globulin (SHBG) in the same group of women when they were
younger [18]. It is known that SHBG decreases with overweight in both, male and female [19–
21]. In the Swedish longitudinal study, SHBG was employed as measure of endocrine signal
in the same group of females when they were in there middle forties, and decades later when
they were analyzed for several parameters besides the CSF/S albumin ratio, such measures
included behavioral evaluations finding that they had cognitive alterations [18]. It strongly
suggests that since youth, these group of obese and overweighting women had less content of
SHBG accompanied in elderly years by BBB disruption and cognitive decline. These data
suggest that an unbalance between the selective entrance and exit of molecules and signaling
drived by a failed BBB filtering can lead to development of dementia, but more experimental
data is needed in order to elucidate the mechanism behind this effect. One way to explain the
cognitive detriment found in these patients could be the diminishment of factors that have
been shown to be protective for the brain, such as SHBG. High levels of SHBG have been
associated with neuroprotection in stroke, vascular and cardiovascular diseases, diabetes [21–
25], and an increased amount of molecules potentially damaging for the brain, such as Aβ [26–
28]. Such idea can be supported by the fact that it was found in the obese and overweight
women, a higher ratio of CSF/S albumin has been observed in subjects with AD as well [29,
30]. In this study, the CSF/S albumin content was measured in 118 patients diagnosed with
AD and clinical data of vascular alterations was registered as well. The AD subjects were
compared with individuals without dementia of the same age, finding a higher albumin ratio
in those with both AD and vascular factors. There was not significant BBB disruption in the
patients without vascular alterations; additionally, there is no correlation with BBB distur‐
bances and age in the control group, which strongly suggests a relationship with the vascular
alterations, BBB disruption, and AD [29]. Controversially in a study, albumin content as well
as IgG in serum and cerebrospinal fluid in several groups of patients with different dementias
such as early-progression familial AD, the senile dementia of Alzheimer type (Late Onset
Alzherimer’s Disease LOAD), and two types of vascular dementia: a group diagnose with
vascular dementia and others with multiinfarct, were measured. The multiinfarct group was
reported with the highest significant alteration of the BBB but not in AD group. All these data
supports the idea that vascular factors associated to BBB disruption are in relationship with
the development of many dementia syndromes and are not restricted to AD [31]. That
controversial information can be clarified with animal experimental data, where several
variables can be controlled. The very first experimental evidence that the Aβ peptide can
actually cross BBB and be deposited in the brain parenchyma was done in 1993 by Zlokovic et
al. [32]. The researchers injected synthetic forms of Aβ peptide: 1–28 and 1–40, which were
labeled with a radioactive marker in order to follow it after carrying out an injection in the
neck vessel of the guinea pigs. The research group found a specific deposition of both synthetic
peptides in the BBB microvasculature, initiating in the luminal side and transcellular transport
into the brain parenchyma. This study strongly supports the idea that the Aβ produced
systemically can cross the BBB. However, the mechanism remains unclear so far.
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Although there is evidence that BBB can be disrupted in patients with dementia, it is possible
that the development on AD can be due to systemically produced Aβ that can cross the BBB
and form the deposits in the brain, but how does this happen? As we reviewed, obese patients
apparently have a disrupted BBB permeability, although, what triggers that? Are the intake
habits involved in such phenomenon? There is experimental evidence that suggest that
components of Western diet, such as cholesterol and saturated fat, can contribute to that
phenomenon. Studies with rabbits fed with a diet containing 2% cholesterol for 8 weeks, have
demonstrated that such type of diet disrupts BBB permeability, alters vascularity, and induce
vessels inflammation and Aβ peptide accumulation in parenchyma [26–28]; and this accumu‐
lation is similar to that observed in brains of AD patients [33]. This body of data, mainly
generated by D.L. Sparks and collaborators, strongly supports the idea that high cholesterol
consumption, importantly, contributes to the development of AD onset by the accumulation
of Aβ, vascular alterations, as well as BBB selective permeability disruption.
The contribution of BBB disruption of a high energetic diet (HE) (approximately 40% Kcal of
fat versus 13% of standard laboratory rodent diet) based on high saturated fat and glucose was
evaluated in 60-days-old 32 male rats that were fed for 90 days with this type of diet. The
researchers evaluated the BBB integrity, measuring by ELISA, the content of sodium fluores‐
cein (NaFl) injected throughout the femoral artery in the prefrontal cortex, striatum, and
hippocampus of the treated rats. They found a significant increased amount of NaFl in the
hippocampus of the treated rats compared with the control but not in prefrontal cortex or in
striatum. They also measured the mRNA expression of tight junction proteins by RT-PCR in
choroid plexus and BBB capillaries. Thigh junction proteins are critical components for
maintenance of selective BBB permeability, its diminishment can alter the BBB function. They
found a decrease expression of the thigh junction proteins and alterations in behavioral task
directly associated with hippocampal function [1]. A further study was carried out by
Davidson et al. [34], where they fed 24 male rats with a high energy diet as well as high
saturated fat and glucose and following for different time points (7, 14, 21 and 28 days),
evaluated BBB integrity by injecting NaFl following the same procedure reported by Kanoski
et al. [1]. They found that the hippocampus was the brain structure that exhibit the highest
concentration of the dye compared with prefrontal cortex and striatum. In this study, the
researchers evaluate the differences between those animals, under HE diet, that show what
they called obesity resistant versus those that developed obesity. The obesity resistant group
was the one that consumed the HE diet but gained the least weight and body fat. The animals
included in the obesity group were those that gained the most bodyweight and fat. It was this
last group that showed the major BBB permeability and had the highest deposit of NaFl in the
hippocampus. Interestingly, they found that those animals, in the HE diet, had the lowest
bodyweight and the lowest amount of fat, and did not show difference in the behavioral
performance compared with the control group. However, those rats that developed obesity
and had the higher deposit of dye in the hippocampus, showed alterations in the performance
of the hippocampal-dependent tasks [34]. These evidences directly shows a relationship
between diets rich in fat, obesity development, and hippocampal-related cognitive alterations.
We will discuss in the next section, the relevance of the hippocampal structure, cognitive
performance, and its detriment.
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From the information reviewed in this section, we can conclude that BBB alteration is a feature
that takes part of dementia onset in both, AD and vascular dementia. Obesity can contribute
to this phenomenon and, although the mechanism is not well known, a particular factor that
can participate in this process is the intake of diets rich in cholesterol or fat, as well as glucose,
those known components of a typical Western diet (Figure 2).
Figure 2. The overproduction of systemic Aβ, produced by consume diets rich on fat or cholesterol, can promote and
alter the selective permeability of BBB, allowing the passage of molecules to the brain, such as systemic Aβ that was
not clear and lead to cerebral amyloidosis and brain inflammation.
4. Impact of a diet rich in cholesterol or fat on the development of AD onset
The hippocampus is a brain structure considered as a part of the allocortex, which is one of
the oldest brain areas from the phylogenetical point of view. It has a high capacity of plasticity;
it is directly involved in learning and memory process and, interestingly, is very susceptible
to damage and has attracted the research focus for several years since it is one of the first brain
structures that degenerate during the AD process [35]. As we reviewed in the last section, the
hippocampus seems to be very susceptible to the effect of consumed diets rich in fat or
cholesterol, but can this actually drive the brain into a degenerative process? Can it contribute
to the development of dementia? We will discuss this idea in the current section. First, we will
review how the diet high in cholesterol or fat can contribute to the development of features
associated with AD, particularly with amyloidosis.
Diets rich in cholesterol, as we have reviewed, can induce vascular inflammation, BBB, and
promotes Aβ peptide accumulation in the brain parenchyma in an animal model of rabbit fed
with high-cholesterol diet [26–28]. Supporting the association of elevated concentrations of
cholesterol and AD detriment in a very recent in vitro study carried out by Avila-Muñoz and
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Arias [36] in isolated astrocytes obtained from brain cortex of 1- to 3-day-old Wistar rats, they
found astrocyte activation, An increase on the expression of amyloid precursor protein (APP),
and promoted its amyloidogenic processing, and an increase in reactive species oxygen (ROS),
a marker of oxidative stress, after treating the culture for 48 h with cholesterol concentrated at
25 or 50 μM. All these parameters measured, including glia activation, resemble features that
have been found in postmortem brain tissues obtained from AD patients [37–39], but how the
consumption of a diet high in cholesterol can contribute to the development of AD? In vivo
studies can answer this question. Transgenic mice Tg2576 (which express the human APP695
carrying the Swedish double mutation at codons 595 and 596, Hsiao et al. [40]), were fed with
a 5% cholesterol diet for 6 weeks. They found an increase of the APP cytosolic fragment but
apparently the hypocholesteremia induced by the diet does not deregulates Aβ metabolism
(George et al, 2004).
In a further work, carried out by Refolo et al [41], with 5-months-old double-mutant for
presenilin (PS) and amyloid precursor protein (PSAPP) mice, which express familial mutant
PS1M146V and the APP695 mutations [42], evaluated the effect of a combined diet with 5%
cholesterol and 10% fat for 7 weeks. They found that the dietary treatment induced elevated
levels of cholesterol in both, plasma and brain, which is an important data since it showed that
brain cholesterol is produced in situ, and this data demonstrates that brain cholesterol is
increased by diet. This increase in brain cholesterol correlates with an increase of total Aβ in
brain. In addition, there was an enhanced amount of Aβ, particularly not in Aβ 1–40 and 1–
42, but in 1–30 and 1–34 as well. This was accompanied with an increase in the number of
Aβ deposits as well as an increase in the plaque area in the hypercholesteremic transgenic
mice. Interestingly, there were no changes found in presenilin 1 (PS1) processing. These data
strongly supported the hypothesis that a diet high in fat and cholesterol can contribute to the
development of amyloidosis, one of the main conditions to develop AD.
Figure 3. As result of consume diets high on fat and cholesterol there is an increase levels of brain cholesterol and sys‐
temic cholesterol. Also elevates Aβ production in brain and its deposit and increases as well the glia activation and
production of ROS in brain. All these together can lead to AD onset.
All these data shows experimental evidence linking the consumption of diets rich in fat
and/or cholesterol with the development of amyloidosis. Nevertheless, dementia is a more
complex syndrome, comprised of many other features such as cognitive decline and neuronal
lost. Particularly in the hippocampus, which is as we mentioned before, one of the first areas
affected during the neurodegenerative process, its susceptibility to suffer alterations resulted
from consuming diets high in fat or cholesterol appears crucial as one of the possible mecha‐
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nism involved in the development of AD (Figure 3). We will discuss that idea in the section
below.
5. Impact on brain morphology, plasticity, and cognition
In the last sections, we have discussed how the consumption of diets rich in fat or cholesterol
can contribute to the production of Aβ peptide in noncerebral tissue. The impact that this could
have in the BBB selective permeability and its participation in brain amyloidosis conditions
that can contribute to the dementia onset but, besides these alterations, one of the main
conditions found in dementia patients is brain atrophy and behavioral alterations. Is brain
functionality affected by the components typically found in the Western diet? Could diet
composition affect brain architecture and plasticity? Moreover, is cognition affected the
consumption of diets rich in fat or cholesterol? We will review such ideas in the current section.
A link between cognitive decline and dietary habits has been proposed. There is an epidemio‐
logical study carried out with Japanese men living in Hawaii compared with age-matched men
living in Japan that evaluated the prevalence of dementia employing the Diagnostic and
Statistical Manual of Mental Disorders. The results found that those subjects living in the USA
have a higher prevalence of dementia: 9.3% for all type dementia, 5.4% for Alzheimer’s disease,
and 4.2% for vascular [43]. Continuing in this line of evidence, there is another study that was
carried out with people from same ethnic background living in their natal land or in a foreign
country (USA). They found in concordance with the study cited before, that those individual
living in Indiana (where the study was carried out on) had a higher prevalence of dementia
compared with age-matched individuals living in Nigeria or Ibadan [44]. This data strongly
suggests that there are some stimuli in this Western country, which contribute to the devel‐
opment of several types of dementia, and the question is: what are these stimuli? A good
candidate are the nutritional habits. In Western countries, especially countries such as the USA
or Mexico, people consume food with high amounts of saturated fat and cholesterol and show
the highest rates of obesity worldwide. The brain is an organ rich in lipids and essential fatty
acids that are mainly obtained from food and have a crucial participation on brain functioning
[45]. So, to think that lipids elevation induced by diet could be in detriment of the brain, which
is a logical assumption, but what are the cellular mechanisms involved in the possible
detrimental effect of food components such as fat and cholesterol? Well, experimental work
has demonstrated evidence of the interplay between obesity, brain alteration, and cognitive
decline, more especially with hippocampal-related cognitive processes. Seminal works in this
area were carried out in the University of Toronto by Greenwood and Winocur [46]. They fed
1-month-old Long-Evans rats with two types of high-fat diets containing 40% of calories: a
saturated fatty acids (lard-based) or a polyunsaturated fatty acids (soybean oil-based) and
compared with a standard laboratory diet containing 4.5% of fat. They tested learning and
memory abilities in the rats after 3 months of dietary treatment with the radial arm maze test,
the variable-interval delayed alternation task, and the Hebb-Williams maze series. These tests
evaluate spatial learning and memory performance and report failures in working or reference
memories. They found that those animals fed with the lard-based diet showed impairment in
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all the tests. Following this line of evidence, they analyzed further with different types of
saturated fatty acid diets: monounsaturated (MUFA) and polyunsaturated (PUFA) fatty acids,
finding a direct relationship between the 3 months consumption of saturated fatty acids and
failures in basic alternation rule, and remembering trial-specific information over time in the
variable-interval delayed alternation task. Interestingly, they found alterations in brain’s
phosphatidylcholine fatty acid profile. However, the changes in the membrane did not
correlate with cognitive alterations [47]. It suggested there is another mechanism elucidating
the cognitive impairment related to consumption of diets rich in fat; a good candidate is brain
inflammation. Chronic inflammation is one of the principal altered events associated with AD
[48], and it has been linked to obesity and has been reported that there is a correlation between
both, obesity and AD [49, 50]. Middle-aged C57BL6 male mice were fed for 21 weeks with
chow equivalent to Western diet containing 41% fat or a high-fat lard diet containing 60% fat
for 16 weeks. They showed an alteration on learning acquisition measured by the Stone T-maze
and it is accompanied by microglial activation, increase expression of cytokines like TNFα,
IL-6, and MCP-1, and a decrease on brain-derivated neurotrophic factor (BNDF) [51]. Inter‐
estingly, there was not any detrimental effect observed in those animals that consumed the
like-Western diet. These data agree with results from Greenwood and Winocur and propose
a possible way underlying the effect diet, which is an inflammation process, and the decrease
on neural factors crucial for learning processes. The results demonstrate that diet can interfere
with learning abilities, but is it everything behind the diet effect on cognitive decline? There
is a report with 344 white middle-aged male Fischer rats. The researchers evaluate the effect
of a diet high in cholesterol and fat (diet containing 2% cholesterol and 10% hydrogenated
coconut oil). The results showed a failure in working memory, here evaluated with the water
radial arm maze as well as elevated lipids profile and reduce expression of Map-2 as an
indicator of alteration of dendritic integrity, which correlates with memory mistakes measured
in the test, and increase in inflammation markers such as microglia activation [52]. In a study
carried out with Sprague-Dawley rats, which were fed for 7 days with high fat and fructose,
several hippocampal alterations, such as decreased insulin signaling, were reported. In
addition, they found that treated animals had a decrease in hippocampus total weight in
addition with some other morphological alterations such as a diminishment on the number of
dendritic spines and a reduction in the complexity of the hippocampal dendritic arborization.
Moreover, there was a decrease in the expression of the microtubule-associated protein 2
(MAP-2) and in the content of synaptophysin in the CA1 region concomitant with an increased
phosphorylation of tau protein, and in the presence of reactive astrocyte associated [53]. It
directly demonstrates alterations in hippocampal cytoarchitecture that definitively have a
strong impact on brain functionality, especially in hippocampal-related learning and memory
processes.
Another feature which affected by consuming diets rich in fat is adult hippocampal neuro‐
genesis (AHN). Adult neurogenesis is a highly specialized plasticity phenomenon that, under
basal conditions, occurs in two restricted brain areas: a) the subventricular zone and b) the
hippocampal dentate gyrus [54, 55]. Hippocampus is a crucial area for memory processes, since
its decrease is associated to memory failures, especially in short-term memory, spatial memory,
and learning flexibility [56–59]. The AHN is a complex process that comprises several devel‐
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opmental steps starting from the division of an endogenous neural precursor cell followed by
its expansion, differentiation, and fully integration to the hippocampal network [60]. These
steps are reported as number of proliferative cells measured by markers of cell division; cell
fate decision with the marker of early differentiation, the cytoeskeleton protein doublecortin
(DCX) that is expressed in newly differentiated cells, and with NeuN, a nuclear marker of
granular cells when the cell is fully differentiated. It has been recently documented that there
are some food components which can regulate the neurogenic process (for a review [61]). The
hippocampal neurogenesis has captured the attention since it was described in 1965 by Dass
and Altman [62] due, as we already mentioned, the hippocampus is closely related to memory
as well as neurodegenerative processes. Juvenile male and female Sprague-Dawley rats under
a dietary regimen of high- (42% coconut butter and corn oil fat) or low-fat diet (10% fat by
energy) or standard laboratory chow for 4 weeks, was found that males under high-fat diet
show less cell proliferation than females and reported elevated levels of corticosterone, a stress
hormone [63]. Differences in AHN were studied in mice susceptible to develop obesity (C57BL/
6N) and obesity resistant (C3H/HeN). They were fed with high- and low-fat diet finding that
those animals that developed obesity and consumed the high-fat diet had much lower number
of proliferative cells and cells committed to neural linage (DCX positive cells), which establish
a clear link between obesity and AHN diminishment [64]. In our laboratory, we have observed
that 8 weeks of diet rich in fat (60%) or high in cholesterol (1.4%) in 5-months-old male Wistar
rats has an impact on AHN in both, cell proliferation and more especially in the morphology
of DCX cells. These cell populations have less processes and a poor complexity than animals
under normal laboratory diet, and we found alterations in short-term memory (Leal-Galicia
and Meraz-Ríos data not yet published). All these data together strongly suggest a detrimental
effect on diets rich in fat or cholesterol in cognitive components such as navigation memory,
working memory, acquisition learning, and short-term memory suggesting as mediators,
alterations in brain cytoarchitecture and AHN, and associates obesity with such cognitive
alterations strongly supporting the hypothesis that obesity can lead to development of
dementia (Figure 4).
Figure 4. The intake of food with high amounts of fat or cholesterol produces alteration in the hippocampus such as:
reduced expression of Map-2, reduction on the number of dendritic spines and in the complexity of the dendritic tree
and a decrease on neurogenesis. Consume diets with these components has also a functional impact in short-term
memory, working memory and learning flexibility, that could contribute to the detriment observed in the dementia
syndrome.
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6. Conclusion
The consumption of diets rich in cholesterol, fat, as well as another components (carbohy‐
drates) of the so called “Western diet” can contribute to increase the production of the peptide
Aβ. This could contribute to brain amyloidosis by means of alteration of the selective perme‐
ability of the BBB, since BBB alterations are induced for these type of diets. In addition, it has
been shown in the brain of transgenic animals that the amyloidosis can be accelerated by the
intake of fat or cholesterol, which can lead to accumulation of Aβ in the brain. Besides that,
the intake of fat or cholesterol can induce alterations in brain morphology and plasticity
accompanied by a detrimental in cognitive abilities in animal models that resemble those
alterations in cognitive abilities reported in AD patients, such as short-term memory, working
memory, and learning flexibility. These evidences strongly suggest an association with the
dietary habits and the possible development of AD in both cases, Early Onset Alzheimer’s
Disease or Late Onset Alzheimer’s Disease, and a connection with systemic disruptions and
brain functions (Figure 5).
Figure 5. Diets rich on fat or cholesterol that are widely consume in Western countries can lead to develop dementia
onset for several ways. One is the overproduction of systemic Aβ that can reach the brain due the chronic consume of
these food components can affect the selective permeability of BBB. It can facilitate the pass of systemic Aβ as well as
another molecules producing brain inflammation and Aβ deposits. It is accompanied for alterations in hippocampal
plasticity and its cytoarchitecture. That can have an impact on brain functionality observed as memory failures. All
these together can contribute to the development of dementia.
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